Cambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for active immunization for the prevention of lower respiratory tract disease ...
As the calendar approaches the middle of November, a lineup of major companies across various sectors is set to report their ...